3. CLINICAL FEATURES
Most commonly affects 3rd and 4th decade
No sex predilection
Either eye or both eye can be affected
Sudden decrease in vision without pain
Loss of colour vision
Loss of contrast sensitivity
Metamorphopsia
4. EVALUATION
Complete history for
Viral infections
Associations with animals
Sexually transmitted diseases
Systemic examination with special emphasis
on neurological examination
5. OCULAR EXAMINATION
RAPD present in unilateral cases
Occasionally, reaction in anterior chamber
Disc oedema which precede appearance of
macular star
Splinter haemorrhages in severe cases
Occasionally, cells in posterior vitreous
Small, discrete chorioretinal lesions in
idiopathic cases
7. Fluorescein Angiography shows diffuse edema
at disc and diffuse leakage of dye from vessels
on the disc surface
Visual field defects - centrocaecal scotoma
(MC), central scotoma and arcuate defects
OCT demonstrates sub- and intraretinal fluid
to a variable extent
8. INVESTIGATIONS
Serological tests for Bartonella, Lyme
disease, syphilis, Toxoplasmosis and
toxocariasis
Mantoux test
Chest X ray
CSF analysis
Neuro-imaging with MRI
9. DIFFERENTIAL DIAGNOSIS
Papilledema (raised ICT)
ONH tumour
Infilterative neuropathy
Vascular diseases
Anterior ischemic optic neuropathy (AION)
Systemic hypertension
Diabetes
PAN
Fluorescein Angiography in above conditions
will show leakage of dye from macula as well,
unlike Neuroretinitis
10. TREATMENT
Resolves spontaneously without treatment
Treatment - speedy recovery and shorter course
of disease
Specific antibiotic therapy
Bartonella - Doxycycline
Syphilis - iv Penicillin
Toxoplasmosis - pyrimethamine, sulfadiazine,
and corticosteroids
Leptospirosis - iv Penicillin, Doxycycline
Recurrent cases - Steroids/immunosuppressant
11. CLINICAL PROGRESSION
Self limiting and recovers spontaneously
Visual progression is very good
Disc oedema resolves in 6-8 weeks
Macular star may resolve in 1 year
Rarely, visual recovery remain poor
Rarely, optic atrophy may be seen
Recurrence is rare